Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostatic adenocarcinoma: considerations in management

D A Pistenma, M A Bagshaw

    Postgraduate Medicine
    |April 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis.

    Cancer·2001
    Same author

    Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer.

    The Prostate·1999
    Same author

    Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer.

    International journal of radiation oncology, biology, physics·1998
    Same author

    Adenocarcinoma of the prostate: innovations in management.

    American journal of clinical oncology·1997
    Same author

    Prostate specific antigen after radiotherapy for prostate cancer: a reevaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University.

    The Journal of urology·1995
    Same author

    Dose escalation with three-dimensional conformal radiotherapy.

    The cancer journal from Scientific American·1995

    Prostatic adenocarcinoma is a leading cause of cancer death in men. Understanding factors influencing prognosis is key to improving patient management, especially when distant metastases are present at diagnosis.

    Area of Science:

    • Oncology
    • Urologic Oncology

    Background:

    • Prostatic adenocarcinoma ranks as the third most frequent cause of cancer mortality among males.
    • Early-stage disease offers potential for cure, but approximately 50% of patients present with distant metastases.

    Purpose of the Study:

    • To enhance the management of prostatic adenocarcinoma by elucidating variables that impact patient prognosis.

    Main Methods:

    • This study focuses on analyzing prognostic variables in prostatic adenocarcinoma.
    • Further details on specific methodologies are not provided in the abstract.

    Main Results:

    • The abstract indicates that 50% of patients are diagnosed with distant metastases.
    • Specific prognostic variables and their impact are not detailed in the provided text.

    Related Experiment Videos

    Conclusions:

    • Improved understanding of prognostic factors is essential for advancing the treatment and outcomes of patients with prostatic adenocarcinoma.